Recombinant DNA Technology Companies

Amgen Acquired Horizon Rectifiers plc, expanding their capabilities in bio-manufacturing and recombinant protein production for biopharmaceuticals.Advanced their development of Bimekizumab, a recombinant humanized monoclonal antibody for treating inflammatory diseases.

Ginkgo Bioworks Inc. (US) Launched their Foundry platform, offering custom strain engineering and cell line development services for biopharmaceutical production using recombinant DNA technology.Partnered with leading drug discovery companies to accelerate the development of novel biotherapeutics.

Intellia Therapeutics Received FDA Fast Track designation for their investigational CRISPR-Cas9 therapy NTLA-2001 for treating transthyretin amyloidosis (ATTR), demonstrating potential for a curative approach.Initiated Phase 1b/2a clinical trials for NTLA-2002, another CRISPR-based therapy for sickle cell disease.

Synthego Collaborated with the University of California, Berkeley, to develop and commercialize novel gene editing technologies for biomanufacturing and synthetic biology applications.Expanded their global manufacturing capacity for recombinant proteins and DNA plasmids used in research and development.

BASF SE (Germany) Established a new biomanufacturing facility in Germany to produce recombinant enzymes and other bio-based products for industrial applications.Partnered with agricultural companies to develop genetically modified crops with improved yields and resistance to pests and diseases.

List of Recombinant DNA Technology Key Companies in the Market

• Amgen Inc. (U.S.)


• Hoffmann-La Roche Ltd (Switzerland)


• Profacgen (U.S.)


• Novartis AG (Switzerland)


• Novo Nordisk A/S (Denmark)


• Genscript Biotech (U.S.)


• Pfizer Inc. (U.S.)


• Sanofi S.A. (France)


• Eli Lilly and Company (U.S.)


• Biogen Inc. (U.S.).